We are a British company established in 2010 with the goal of improving the efficiency and safety of minimally invasive surgery through the development and commercialisation of products that maintain uncompromised surgical vision. The OpClear platform, launched in 2013, shields the laparoscope’s lens from condensation and particulates through an intelligent CO2 flow at its tip and removes visual obstructions with an on demand CO2 and saline lens wash, allowing procedures to continue with minimal disruption. Cipher Surgical is focused on research and development, investing 35% of expenditure annually on product advancements. Projects include clinical research to validate the impact of the OpClear platform on patient outcomes. This work enables physicians and hospitals to make evidence-based decisions. Our goal is to make in-situ lens cleaning the standard of care by scientifically demonstrating its true value to healthcare systems worldwide.